(Q54381625)

29 May 2018

title

Properties of post-infusion factor VIII in Von Willebrand's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

2 February 2023

author name string

R. H. Muntz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4547286

2 February 2023

H. Ekert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4547286

2 February 2023

H. Helliger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4547286

2 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4547286

2 February 2023

publication date

1 August 1974

1 reference

29 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0049384874900620?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

https://api.elsevier.com/content/article/PII:0049384874900620?httpAccept=text/plain

2 February 2023

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

2 February 2023

1 reference

29 May 2018

volume

5

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

page(s)

111-123

1 reference

29 May 2018

On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Transfusion studies in von Willebrand's disease

2 February 2023

2

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia

2 February 2023

5

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Low-molecular-weight factor VIII

2 February 2023

6

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates

2 February 2023

8

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

2 February 2023

10

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity

2 February 2023

16

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content

2 February 2023

20

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Von Willebrand's disease type B: a newly defined bleeding diathesis

2 February 2023

22

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

Antigen-biological-activity ratio for factor VIII.

2 February 2023

23

1 reference

https://api.crossref.org/works/10.1016/0049-3848(74)90062-0

2 February 2023

Identifiers

1 reference

29 May 2018

1 reference

29 May 2018